Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2025-03-25 | Vaddi Krishna | CEO | Buy | 675,000 | $0.69 | $467,437.50 | +51.0% | → |
| 2025-03-25 | Combs Andrew | Chief Chemistry Officer | Buy | 100,000 | $0.69 | $69,250.00 | +26.3% | → |
| 2025-03-21 | Vaddi Krishna | CEO | Buy | 20,416 | $0.73 | $14,909.43 | +0.8% | → |
| 2025-03-17 | Vaddi Krishna | CEO | Buy | 39,105 | $0.75 | $29,459.84 | +1.5% | → |
| 2025-03-13 | Vaddi Krishna | CEO | Buy | 97,500 | $0.71 | $69,564.00 | +4.1% | → |
| 2024-12-31 | Vaddi Krishna | CEO | Buy | 5,000 | $1.21 | $6,043.50 | +3.6% | → |
| 2024-12-30 | Vaddi Krishna | CEO | Buy | 10,000 | $1.20 | $12,000.00 | +7.8% | → |
| 2024-12-23 | Combs Andrew | Chief Chemistry Officer | Buy | 63,075 | $1.36 | $85,538.25 | +10.0% | → |
| 2024-12-19 | Lim Bryant David | CLO, Interim CFO, Corp Sec. | Buy | 25,000 | $0.91 | $22,637.50 | +1,042% | → |
| 2024-12-19 | Vaddi Krishna | CEO | Buy | 106,888 | $0.93 | $99,325.86 | +9.0% | → |
| 2023-05-25 | Vaddi Krishna | CEO | Buy | 1,900 | $5.15 | $9,790.40 | - | → |
| 2023-05-24 | Lim Bryant David | Chief Legal Officer, Corp Sec. | Buy | 2,400 | $5.39 | $12,936.00 | New | → |
| 2023-05-23 | Vaddi Krishna | CEO | Buy | 11,856 | $5.63 | $66,749.28 | +1.1% | → |
| 2023-05-23 | Chardonnet Laurent | Chief Financial Officer | Buy | 5,000 | $5.50 | $27,500.00 | +13.5% | → |
| 2023-05-22 | Bonita David P | - | Buy | 869,565 | $5.75 | $4,999,998.75 | +9.4% | → |
| 2023-05-22 | ORBIMED ADVISORS LLC | - | Buy | 869,565 | $5.75 | $4,999,998.75 | +9.4% | → |
| 2023-04-06 | Huang Jane | President, CMO | Sale+OE | 13,280 | $6.12 | $81,273.60 | -35.4% | → |
| 2022-12-20 | Vaddi Krishna | CEO | Buy | 19,188 | $5.13 | $98,445.95 | +18.9% | → |
| 2022-12-08 | Chardonnet Laurent | Chief Financial Officer | Buy | 10,000 | $4.76 | $47,600.00 | +38.7% | → |
| 2022-06-01 | Chardonnet Laurent | Chief Financial Officer | Buy | 10,000 | $4.23 | $42,300.00 | +69.0% | → |
| 2021-12-15 | Morosini Deborah | EVP, Chief of Clinical Affairs | Sale+OE | 28,751 | $13.00 | $373,763.00 | -98.5% | → |
| 2021-12-14 | Combs Andrew | EVP, Head of Chemistry | Buy | 8,000 | $11.86 | $94,880.00 | +1.5% | → |
| 2021-11-16 | Morosini Deborah | EVP, Chief of Clinical Affairs | Sale+OE | 28,751 | $15.88 | $456,531.56 | -95.7% | → |
| 2021-10-05 | Mauro David J | Chief Medical Officer | Sale+OE | 15,000 | $30.96 | $464,349.91 | -59.1% | → |
| 2021-09-07 | Mauro David J | Chief Medical Officer | Sale+OE | 15,000 | $36.69 | $550,282.55 | -55.2% | → |
| 2021-09-02 | Pierce Christopher | EVP and Chief of Business Oper | Sale+OE | 17,000 | $41.68 | $708,492.70 | -34.8% | → |
| 2021-08-27 | Scherle Peggy | Chief Scientific Officer | Sale+OE | 7,714 | $35.75 | $275,786.75 | -1.1% | → |
| 2021-08-25 | Piper Brian | Chief Financial Officer | Sale+OE | 8,333 | $33.34 | $277,827.45 | -49.3% | → |
| 2021-08-13 | Scherle Peggy | Chief Scientific Officer | Sale+OE | 2,286 | $35.07 | $80,161.33 | -1.3% | → |
| 2021-08-05 | Mauro David J | Chief Medical Officer | Sale+OE | 8,784 | $31.88 | $280,061.60 | -55.9% | → |